MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Book Value 2011-2026 | ABT
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.7 B | 81.4 B | 73.2 B | 74.4 B | 75.2 B | 72.5 B | 31.3 B | 30.7 B | 31.1 B | 20.7 B | 21.3 B | 21.6 B | 25.3 B | 26.8 B | 24.5 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 86.7 B | 20.7 B | 46.5 B |
Quarterly Book Value Abbott Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84 B | 81.4 B | 74.4 B | 73 B | 72.5 B | 72.1 B | 73.4 B | 73.8 B | 74.4 B | 72.8 B | - | 74 B | 75.2 B | 73.8 B | 73.3 B | 72.8 B | 72.5 B | 72.5 B | 72.5 B | 72.5 B | 67.9 B | 67.9 B | 67.9 B | 67.9 B | 67.2 B | 67.2 B | 67.2 B | 67.2 B | 76.2 B | 76.2 B | 76.2 B | 76.2 B | 52.7 B | 52.7 B | 52.7 B | 52.7 B | 41.2 B | 41.2 B | 41.2 B | 41.2 B | 41.2 B | 41.3 B | 41.3 B | 41.3 B | 42.9 B | 43 B | 43 B | 43 B | 67.2 B | 67.2 B | 67.2 B | 67.2 B | 60.3 B | 60.3 B | 60.3 B | 60.3 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 84 B | 41.2 B | 63.3 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
FONAR Corporation
FONR
|
146 M | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.53 B | $ 12.0 | -0.58 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
Globus Medical
GMED
|
4.57 B | $ 90.43 | 2.07 % | $ 12.2 B | USA |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 9.11 | -2.88 % | $ 258 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.82 B | $ 36.38 | -0.98 % | $ 5.42 K | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 1.8 | -5.53 % | $ 1.09 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.55 B | $ 9.25 | -0.64 % | $ 712 M | USA |
 |
Inspire Medical Systems
INSP
|
781 M | $ 54.48 | 0.63 % | $ 1.6 B | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.03 | 3.35 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 85.52 | -0.13 % | $ 2.97 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
-12.2 M | $ 5.77 | -2.04 % | $ 69 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 15.82 | -0.75 % | $ 371 M | USA |
 |
Medtronic PLC
MDT
|
48.3 B | $ 86.33 | 0.06 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
56.9 M | $ 3.42 | -1.16 % | $ 128 M |  France |
 |
Myomo
MYO
|
11.4 M | $ 0.67 | -4.85 % | $ 28 M | USA |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
3.85 B | $ 168.21 | -2.13 % | $ 12.6 B | USA |
 |
Orthofix Medical
OFIX
|
450 M | $ 11.81 | 0.34 % | $ 468 M |  Curacao |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
129 M | $ 31.01 | -4.99 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Insulet Corporation
PODD
|
1.52 B | $ 204.23 | 0.36 % | $ 14.4 B | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
2.93 M | $ 2.76 | 9.09 % | $ 7.65 M | USA |
 |
Smith & Nephew plc
SNN
|
5.29 B | $ 31.76 | -2.67 % | $ 23.8 B |  Britain |
 |
Butterfly Network
BFLY
|
169 M | $ 4.02 | -2.66 % | $ 851 M | USA |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
22.4 B | $ 331.18 | -0.34 % | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
219 M | $ 24.16 | -1.67 % | $ 553 M | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
TELA Bio
TELA
|
6.31 M | $ 0.7 | 11.11 % | $ 32.9 M | USA |
 |
TransMedics Group
TMDX
|
473 M | $ 107.91 | 2.97 % | $ 3.67 B | USA |
 |
Tandem Diabetes Care
TNDM
|
155 M | $ 18.66 | -2.66 % | $ 1.27 B | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 9.68 | -0.21 % | $ 347 M | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 61.33 | -2.01 % | $ 90.8 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 11.09 | 1.05 % | $ 1.66 B | USA |